Brief: Laboratorio Farmaceutico Erfo H1 EBITDA EUR 1.2 Mln
28/08/2025 12:02
Aug 28 (Reuters) - Laboratorio Farmaceutico Erfo SpA ERFO.MI: H1 EBITDA EUR 1.2 MILLION H1 CONSOLIDATED REVENUE EUR 5.2 MILLION H1 EBITDA MARGIN 23% Further company coverage: ERFO.MI (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Laboratorio Farmaceutico Erfo SpA
See all newsBrief: Laboratorio Farmaceutico Erfo Signs Patent Box Agreement For 2021–2024, Estimates Net Fiscal Benefit Of €0.3 Mln
Brief: Laboratorio Farmaceutico Erfo H1 Adjusted EBITDA EUR 1.3 Million
Brief: Laboratorio Farmaceutico Erfo Q1 EBITDA Adj. EUR 0.5 Mln
Brief: Laboratorio Farmaceutico Erfo FY EBITDA EUR 2.0 Mln
Brief: Laboratorio Farmaceutico Erfo 9M EBITDA EUR 1.7 Mln